93 related articles for article (PubMed ID: 15664646)
1. Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles.
Tosi G; Rivasi F; Gandolfi F; Costantino L; Vandelli MA; Forni F
Biomaterials; 2005 Jul; 26(19):4189-95. PubMed ID: 15664646
[TBL] [Abstract][Full Text] [Related]
2. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z
J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106
[TBL] [Abstract][Full Text] [Related]
4. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
Tosi G; Costantino L; Rivasi F; Ruozi B; Leo E; Vergoni AV; Tacchi R; Bertolini A; Vandelli MA; Forni F
J Control Release; 2007 Sep; 122(1):1-9. PubMed ID: 17651855
[TBL] [Abstract][Full Text] [Related]
5. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
6. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide).
Berkland C; Pack DW; Kim KK
Biomaterials; 2004 Nov; 25(25):5649-58. PubMed ID: 15159081
[TBL] [Abstract][Full Text] [Related]
7. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
8. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
[TBL] [Abstract][Full Text] [Related]
9. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
11. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.
Fischer S; Foerg C; Ellenberger S; Merkle HP; Gander B
J Control Release; 2006 Mar; 111(1-2):135-44. PubMed ID: 16377017
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
14. Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide).
Shen H; Hu X; Yang F; Bei J; Wang S
Biomaterials; 2007 Oct; 28(29):4219-30. PubMed ID: 17618682
[TBL] [Abstract][Full Text] [Related]
15. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N
Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195
[TBL] [Abstract][Full Text] [Related]
17. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
18. Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system.
Kirthivasan B; Singh D; Bommana MM; Raut SL; Squillante E; Sadoqi M
Nanotechnology; 2012 Jun; 23(25):255102. PubMed ID: 22652439
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
20. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
Gao H; Wang YN; Fan YG; Ma JB
J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
